Pseudomonas aeruginosa


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

Pseudomonas aeruginosa

[‚süd·ə‚mōn·əs ‚ar·ə·jə′nō·sə]
(microbiology)
An opportunistic pathogen that is the most significant cause of hospital-acquired infections, particularly in predisposed patients with metabolic, hematologic, and malignant diseases. It produces toxic factors such as lipase, esterase, lecithinase, elastase, and endotoxin, some of which may contribute to its pathogenesis.
References in periodicals archive ?
TABLE 1 Mean Number of Culturable Pseudomonas aeruginosa Colonies Recovered by Time (Hours) Method Mean # of Culturable Pseudomonas aeruginosa Colonies Recovered Swab Time 0 0.
Pseudomonas aeruginosa aerobik gram negatif bakteri olup ozellikle immun sistemin etkilendigi altta yatan kronik hastaligi olan hastalarda firsatci enfeksiyonlara yol acar (5).
3,4] However, there have been case reports of extrapulmonary spread of Pseudomonas aeruginosa in immunocompetent CF patients chronically infected with the mucoid strain of this organism with bacteremia, endopthalmitis and pericarditis.
Pseudomonas aeruginosa carbapenem resistance mechanism in Spain: impact on the activity of imipenem, meropenem and doripenem.
Characterization and micellization of rhamnolipidic fractions and crude extracts produced by Pseudomonas aeruginosa mutant MIG-N146.
6] Toama MA, Hamed IM, Ashour SM Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
Pseudomonas aeruginosa exhibits resistance to a variety of penicillins and cephalosporins, mediated by an alteration in porin proteins that form channels in the cell membrane (7).
Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units.
Pseudomonas aeruginosa is present in 30 to 50% of these cases and the majority are observed in intravenous drug users.
The case of a 43 year-old healthy male with Pseudomonas aeruginosa pneumonia causing septic shock and multiorgan failure within 48 hours of admission is presented.
Intercell's prophylactic vaccine consists of two outer membrane proteins of Pseudomonas aeruginosa, a bacterium that infects mainly people with immunodeficiency and causes urinary tract infections, sepsis, pneumonia, pharyngitis and other infections.